As of 2025-09-16, the Relative Valuation of Enanta Pharmaceuticals Inc (ENTA) is (59.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.46 USD, the upside of Enanta Pharmaceuticals Inc based on Relative Valuation is -893.2%.
The range of the Relative Valuation is (58.79) - (74.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 18.8x | 13.6x |
| Forward P/E multiples | 13.7x - 17.3x | 13.9x |
| Fair Price | (58.79) - (74.28) | (59.18) |
| Upside | -888.0% - -1095.7% | -893.2% |
| Date | P/E |
| 2025-09-15 | -1.73 |
| 2025-09-12 | -1.92 |
| 2025-09-11 | -2.01 |
| 2025-09-10 | -1.94 |
| 2025-09-09 | -2.10 |
| 2025-09-08 | -2.07 |
| 2025-09-05 | -2.06 |
| 2025-09-04 | -2.07 |
| 2025-09-03 | -2.05 |
| 2025-09-02 | -2.09 |
| 2025-08-29 | -1.95 |
| 2025-08-28 | -2.02 |
| 2025-08-27 | -1.98 |
| 2025-08-26 | -2.01 |
| 2025-08-25 | -2.01 |
| 2025-08-22 | -2.05 |
| 2025-08-21 | -2.00 |
| 2025-08-20 | -2.05 |
| 2025-08-19 | -1.95 |
| 2025-08-18 | -1.90 |
| 2025-08-15 | -1.86 |
| 2025-08-14 | -1.80 |
| 2025-08-13 | -1.76 |
| 2025-08-12 | -1.59 |
| 2025-08-11 | -1.51 |
| 2025-08-08 | -1.60 |
| 2025-08-07 | -1.62 |
| 2025-08-06 | -1.65 |
| 2025-08-05 | -1.72 |
| 2025-08-04 | -1.65 |
| 2025-08-01 | -1.65 |
| 2025-07-31 | -1.76 |
| 2025-07-30 | -1.77 |
| 2025-07-29 | -1.88 |
| 2025-07-28 | -1.87 |
| 2025-07-25 | -1.72 |
| 2025-07-24 | -1.71 |
| 2025-07-23 | -1.80 |
| 2025-07-22 | -1.78 |
| 2025-07-21 | -1.80 |
| 2025-07-18 | -1.75 |
| 2025-07-17 | -1.68 |
| 2025-07-16 | -1.65 |
| 2025-07-15 | -1.53 |
| 2025-07-14 | -1.62 |
| 2025-07-11 | -1.52 |
| 2025-07-10 | -1.62 |
| 2025-07-09 | -1.66 |
| 2025-07-08 | -1.80 |
| 2025-07-07 | -1.78 |